Skip to main content
SpringerLink
Log in

Hepatic Metastasectomy for Testicular Germ Cell Tumors: Is it worth it?

  • 2008 SSAT Poster Presentation Manuscript
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Chemotherapy is highly effective for metastatic germ cell tumor (GCT), but experience with resection of hepatic metastases from GCT is limited.

Methods

Fifteen patients with GCT metastatic to the liver underwent 16 hepatic operations (1975–2002). Pre-resection therapy, surgical pathology, and operative outcomes were reviewed. All patients were followed to death or last contact for survival and disease status.

Results

Patients underwent biopsy (three), wedge resection (nine), bisegmentectomy (two), and major lobectomy (two). Hepatic histology included: necrosis (33%), viable tumor (27%), mature teratoma (13%), and benign histology (27%). Concomitant resection of extrahepatic disease (14 patients, 93%) found necrosis (53%), mature teratoma (27%), and viable tumor (13%). Operative mortality was 0% and morbidity was 40%. At 8.2 years (mean) from resection, 11 patients (73%) were alive: five with no evidence of disease, two with elevated tumor marker only, and four with gross disease. Four patients (27%) died. The 10-year overall survival was 62% from diagnosis.

Conclusion

Resection of post-chemotherapy hepatic disease is safe, even when combined with resection of extrahepatic residual disease. The varied histologic findings, lack of reliable predictors, and prolonged survival achieved support a multidisciplinary approach which includes surgical resection of hepatic metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

Similar content being viewed by others

References

  1. McGlynn KA, Devesa SS, Sigurdson AJ, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63–70. doi:10.1002/cncr.11054.

    Article  PubMed  Google Scholar 

  2. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242–253. doi:10.1056/NEJM199707243370406.

    Article  PubMed  Google Scholar 

  3. International Germ Cell Consensus Classification. A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594–603.

    Google Scholar 

  4. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377–1399. doi:10.1093/annonc/mdh301.

    Article  PubMed  Google Scholar 

  5. Sim HG, Lange PH, Lin DW. Role of post-chemotherapy surgery in germ cell tumors. Urol Clin North Am 2007;34:199–217. abstract ix. doi:10.1016/j.ucl.2007.02.010.

    Article  PubMed  Google Scholar 

  6. Katz MH, McKiernan JM. Management of non-retroperitoneal residual germ cell tumor masses. Urol Clin North Am 2007;34:235–243. abstract x. doi:10.1016/j.ucl.2007.02.004.

    Article  PubMed  Google Scholar 

  7. Toner GC. The challenge of poor-prognosis germ cell tumors. Urol Clin North Am 2007;34:187–197. abstract ix. doi:10.1016/j.ucl.2007.02.016.

    Article  PubMed  Google Scholar 

  8. Hartmann JT, Rick O, Oechsle K, et al. Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors. Ann Surg 2005;242:260–266. doi:10.1097/01.sla.0000171303.32006.a2.

    Article  PubMed  Google Scholar 

  9. Rivoire M, Elias D, De Cian F, et al. Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery. Cancer 2001;92:578–587. doi:10.1002/1097-0142(20010801)92:3<578::AID-CNCR1357>3.0.CO;2-C.

    Article  PubMed  Google Scholar 

  10. Practice guidelines in oncology: testicular cancer. National Comprehensive Cancer Network. In; 2008. www.nccn.org.

  11. Liu D, Abolhoda A, Burt ME, et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 1998;66:1709–1714. doi:10.1016/S0003-4975(98)00940-0.

    Article  PubMed  Google Scholar 

  12. Rasco DW, Assikis V, Marshall F. Integrating metastasectomy in the management of advanced urological malignancies—where are we in 2005. J Urol 2006;176:1921–1926. doi:10.1016/j.juro.2006.07.003.

    Article  PubMed  Google Scholar 

  13. Goulet RJ Jr, Hardacre JM, Einhorn LH, et al. Hepatic resection for disseminated germ cell carcinoma. Ann Surg 1990;212:290–293. discussion 293–294. doi:10.1097/00000658-199009000-00007.

    Article  PubMed  Google Scholar 

  14. Hahn TL, Jacobson L, Einhorn LH, Foster R, Goulet RJ Jr. Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 1999;6:640–644. doi:10.1007/s10434-999-0640-0.

    Article  PubMed  Google Scholar 

  15. Bajorin DF, Motzer RJ, Bosl GJ. Germ cell tumors. Curr Ther Endocrinol Metab 1997;6:387–92.

    PubMed  Google Scholar 

  16. Kollmannsberger C, Honecker F, Bokemeyer C. Treatment of germ cell tumors—update 2006. Ann Oncol 2006;17(Suppl 10):x31–x35. doi:10.1093/annonc/mdl232.

    Article  PubMed  Google Scholar 

  17. Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. Semin Urol Oncol 2002;20:262–271. doi:10.1053/suro.2002.36977.

    Article  PubMed  Google Scholar 

  18. Beck SD, Patel MI, Sheinfeld J. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. J Urol 2004;171:168–171. doi:10.1097/01.ju.0000099714.16082.78.

    Article  PubMed  Google Scholar 

  19. Albers P, Weissbach L, Krege S, et al. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 2004;171:1835–1838. doi:10.1097/01.ju.0000119121.36427.09.

    Article  PubMed  Google Scholar 

  20. Cheng L, Zhang S, Wang M, et al. Molecular genetic evidence supporting the neoplastic nature of stromal cells in ‘fibrosis’ after chemotherapy for testicular germ cell tumours. J Pathol 2007;213:65–71. doi:10.1002/path.2202.

    Article  PubMed  Google Scholar 

  21. Houldsworth J, Korkola JE, Bosl GJ, Chaganti RS. Biology and genetics of adult male germ cell tumors. J Clin Oncol 2006;24:5512–5518. doi:10.1200/JCO.2006.08.4285.

    Article  PubMed  Google Scholar 

  22. Carver BS, Serio AM, Bajorin D, et al. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J Clin Oncol 2007;25:5603–5608. doi:10.1200/JCO.2007.13.6283.

    Article  PubMed  Google Scholar 

  23. Carver BS, Shayegan B, Serio A, et al. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007;25:1033–1037. doi:10.1200/JCO.2005.05.4791.

    Article  PubMed  Google Scholar 

  24. Antoniou A, Lovegrove RE, Tilney HS, et al. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery 2007;141:9–18. doi:10.1016/j.surg.2006.07.045.

    Article  PubMed  Google Scholar 

  25. O’Rourke TR, Tekkis P, Yeung S, et al. Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 2008;15:207–218. doi:10.1245/s10434-007-9649-4.

    Article  PubMed  Google Scholar 

  26. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008;247:125–135.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General and Gastroenterologic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA

    Y. Nancy You & Florencia G. Que

  2. Department of Urology, Mayo Clinic, Rochester, MN, USA

    Bradley C. Leibovitch

Authors
  1. Y. Nancy You
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradley C. Leibovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Florencia G. Que
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florencia G. Que.

Additional information

Presented at Digestive Disease Week, May 2008, San Diego, California

Rights and permissions

Reprints and permissions

About this article

Cite this article

You, Y.N., Leibovitch, B.C. & Que, F.G. Hepatic Metastasectomy for Testicular Germ Cell Tumors: Is it worth it?. J Gastrointest Surg 13, 595–601 (2009). https://doi.org/10.1007/s11605-009-0807-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-009-0807-9

Keywords

Search

Navigation